How Scientists Built a ‘Living Drug’ to Beat Cancer
Researchers didn’t know if it would work, but they had little to lose when they tried a new drug known as a CAR-T—a living cell reprogrammed to recognize and kill leukemia—on a dying 6-year-old.
Researchers didn’t know if it would work, but they had little to lose when they tried a new drug known as a CAR-T—a living cell reprogrammed to recognize and kill leukemia—on a dying 6-year-old.
